Pulmonary Fibrosis Awareness
Pulmonary fibrosis (PF), essentially scarring of the lungs, affects millions of people worldwide and is a major source of distress. In the United States alone there are upwards of 150,000 patients whose condition is idiopathic—the source of their suffering is unknown.
What we do know is that scarring is a normal response to injury—such as infection, smoke inhalation, or radiation therapy, among other causes—but PF is different. The scar response occurs but gets progressively out of control as scar tissue replaces healthy tissue in the lungs, which impedes the body’s ability to draw oxygen from each breath.
The Jane and Leonard Korman Respiratory Institute, a partnership between Jefferson Health and National Jewish Health, is working to discover answers to what causes PF and better ways to treat the condition, through forward-thinking basic science and translational research. Part of this effort involves raising awareness by engaging with patients and their communities, empowering them with the information they need to make decisions and be their own best advocate.
To get the word out about PF and the world-class care available at Jefferson, the Korman Institute is celebrating Pulmonary Fibrosis Month this September by launching a PF patient support group and engaging with the wider Philadelphia community.
Please join us so we can breathe easier—together.